The World Anti-Doping Code 2015 : ASSER International Sports Law Blog symposium

The World Anti-Doping Code 2015 : ASSER International Sports Law Blog symposium / Antoine Duval, Herman Ram, Marjolaine Viret, Emily Wisnosky, Howard L. Jacobs, Mike Morgan. – (International Sports Law Journal 16 (2016) 1 (July) : page 99-117). - DOI: 10.1007/s40318-016-0097-9

Abstract:

This article brings together the contributions to a blog symposium on the new World Anti-Doping Code 2015 published on the ASSER International Sports Law Blog in October 2015. The contributions cover a variety of subjects, including the new sanctioning regime, the role of national anti-doping authorities, the working of therapeutic use exemptions and the increasing role played by the notion of intent under the WADC 2015.

Content:

1. Introduction
1.1 The WADA and its code: a schort history
1.2 Making the code 2015: the legislative process
1.3 The blog symposium on the WADA code 2015
2. The impact of the revised WADC on the work of NADOs
2.1 Introduction
2.2 Sanctions
2.3 Proportionality and human rights
2.4 Investigation and intelligence
2.5 Athlete support personnel (ASP)
2.6 Smart testing and analyzing
2.7 International federations and NADOs
2.8 A clearer and shorter code
2.9 Miscellaneous
3. The “Athlete Patient” and the 2015 Code: competing under medical treatment
3.1 Introduction
3.2 Obtaining clearance to compete – therapeutic use exemptions and conditional prohibitions
3.2.1 Amendments to procedural requirements for granting a TUE
3.2.2 Amendments to substantive requirements for granting a TUE
3.2.3 Transparency for conditionally prohibited substances
3.3 Sanctons for legitimate medical treatment without a TUE
3.4 Conclusion – remember health considerations behind anti-doping
4. “Proof of intent (or lack thereof) under the 2015 World Anti-Doping Code”
4.1 Why intent matters under the 2015 World Anti-Doping Code
4.2 How will the NADO/IF prove “intent” in cases involving “specified substance”
4.3 How does the athlete prove “no intent” in cases not involving “specified substances”?
5. Conclusion
6. Ensuring proportionate sanctions under the 2015 WADA Code
6.1 Introduction
6.2 Context
6.2.1 The Katrin Krabbe case
6.2.2 Specified substances
6.2.3 The rise and fall of “aggravating circumstances”
6.2.4 Proportionality
6.3 Comment
6.4 Concluding remark

Original document

Parameters

Date
10 June 2016
People
Duval, Antoine
Jacobs, Howard L.
Morgan, Mike
Ram, Herman
Viret, Marjolaine
Wisnosky, Emily
Country
Netherlands
Switzerland
United Kingdom
United States of America
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Aggravating circumstances
Anti-Doping policy
Case law / jurisprudence
Human rights
International Standard for Laboratories (ISL)
International Standard for Therapeutic Use Exemptions (ISTUE)
No intention to cheat
No intention to enhance performance
Period of ineligibility
Principle of proportionality
Revision
Rules & regulations International Sports Federations
Rules & regulations National Sports Organisations & National Anti-Doping Organisations
Statute of limitation
Strict liability
WADA Code, Guidelines, Protocols, Rules & Regulations
WADA Prohibited List International Standard
Other organisations
Dopingautoriteit - Anti-Doping Authority Netherlands (ADAN)
T.M.C. Asser Institute
Tribunal Arbitral du Sport (TAS) - Court of Arbitration for Sport (CAS)
Université de Neuchâtel - University of Neuchâtel (UniNE)
World Anti-Doping Agency (WADA)
Analytical aspects
Testing method development
Doping classes
S2. Peptide Hormones, Growth Factors
S9. Glucocorticosteroids
Medical terms
Legitimate Medical Treatment
Therapeutic Use Exemption (TUE)
Various
Anti-Doping investigation
Athlete support personnel
Document category
Scientific article
Document type
Pdf file
Date generated
9 August 2016
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin